You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ROIV Sale Disclosure
Venker Eric · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$1.23M
Venker Eric President & Immunovant CEO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Aug 28, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 4 days later
ROIV daily price context
Close on/before transaction
$34.71
Aug 28, 2026
First close after public filing
$34.18
Sep 2, 2026
30-day return after filing
+3.86%
Through Oct 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 33,818 shares @ $36.44
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-035375
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$7.92M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV Current | Sale | Aug 28, 2026 | $1.23M |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 28, 2026 | $770K |
| Roivant Sciences Ltd. ROIV | Sale | Aug 28, 2026 | $5.92M |
| Roivant Sciences Ltd. ROIV | Exercise | Aug 28, 2026 | $0 |